Publikasjoner

Publikasjoner fra NGICG og undergrupper (PubMed)

NGICG-ØV

Claassen YHM, Bastiaannet E, Hartgrink HH, et al. International comparison of treatment strategy and survival in metastatic gastric cancer. BJS Open. 2018;3(1):56-61. Published 2018 Oct 9. doi:10.1002/bjs5.103

 

Claassen YHM, Dikken JL, Hartgrink HH, et al. North European comparison of treatment strategy and survival in older patients with resectable gastric cancer: A EURECCA upper gastrointestinal group analysis. Eur J Surg Oncol. 2018;44(12):1982-1989. doi:10.1016/j.ejso.2018.09.014

 

 

NGICG-CR

Bahadoer RR, Bastiaannet E, Claassen YHM, van der Mark M, van Eycken E, Verbeeck J, et al. One-year excess mortality and treatment in surgically treated patients with colorectal cancer: A EURECCA European comparison. Eur J Surg Oncol 2021


Breugom AJ, Bastiaannet E, Guren MG, Korner H, Boelens PG, Dekker FW, et al. Treatment strategies and overall survival for incurable metastatic colorectal cancer - A EURECCA international comparison including 21,196 patients from the Netherlands and Norway. Eur J Surg Oncol 2020; 46: 1167-73.


Stormark K, Krarup PM, Sjovall A, Soreide K, Kvaloy JT, Nordholm-Carstensen A, et al. Anastomotic leak after surgery for colon cancer and effect on long-term survival. Colorectal Dis 2020; 22: 1108-18.


Wasmuth HH, Faerden AE, Myklebust TA, Pfeffer F, Norderval S, Riis R, et al. Transanal total mesorectal excision for rectal cancer has been suspended in Norway. Br J Surg 2020; 107: 121-30.


Larsen SG, Pfeffer F, Korner H, Norwegian Colorectal Cancer G. Norwegian moratorium on transanal total mesorectal excision. Br J Surg 2019; 106: 1120-1.

Tidsskriftet tema Kolorektal kreft 2007

Tidsskriftet hadde i 2007 en serie artikler med temaet Kolorektalkreft hvor NGICG bidro

Nationwide improvement of rectal cancer treatment outcomes in Norway, 1993-2010

Kolorektalcancerregisteret har publisert en artikkel i 2015 som gir god bakgrunn og resultater for rectumcancer fra oppstart av Rectumcancerregisteret i 1993 og frem til 2010. Artikkelen er trykket i Acta Oncologica og Marianne Grønlie Guren er førsteforfatter. Artikkelen finner du her: